Abstract
The patch-clamp technique offers unparalleled insight into the electrical and biophysical behavior of excitable cells. However, it is a slow and low-throughput method that typically requires cells to be measured one by one. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are regularly subjected to this technique to unravel the molecular mechanisms of cardiac diseases. Their use in direct patient treatment and successful drug development has been limited due to the lack of applicable high-throughput patch-clamp methods suited to successful hiPSC-CM measurement. Here we present a protocol employing a patch-clamp robot that addresses these limitations by using planar patch-clamp technology. We outline how to collect and handle hiPSC-CM for these experiments, along with optimized patch-clamp protocols for direct functional measurement of major cardiac ion channels including Kir2.1, NaV1.5, CaV1.2, Kv11.1 and Kir3.1/3.4. We further explain how the liquid-handling properties of this setup allow multiple patch-clamp protocols to be combined in sequence while the cell remains in whole-cell configuration. This allows for over a hundred-fold increase in functional data acquisition. These procedures can be carried out within 1 d by both skilled and non-electrophysiologists; however, some experience in cell culture and handling is required. Overall, this protocol enhances fast and reliable functional characterization of hiPSCl-CM and may increase their applicability for rapid and safe drug development.
Key points
-
Human induced pluripotent stem cell-derived cardiomyocytes are useful constructs in the study of cardiac disease mechanisms. This protocol highlights how to extract broad electrophysiological features from these constructs in high throughput.
-
Typical patch-clamp measurements suffer from low throughput and represent a major bottleneck in disease modeling and drug development. This protocol removes this limitation through the combination of simultaneous population patch-clamp and robotic liquid handling.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Data availability
The main data discussed in this protocol are available from the supporting primary research papers.
References
Seibertz, F. et al. A modern automated patch-clamp approach for high throughput electrophysiology recordings in native cardiomyocytes. Commun. Biol. 5, 969 (2022).
Thomas, D. et al. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management. Clin. Res. Cardiol. 108, 577–599 (2019).
Cyganek, L. et al. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes. JCI Insight 3, e99941 (2018).
Kyriakopoulou, E. et al. Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy. Nat. Cardiovasc. Res. 2, 1262–1276 (2023).
Seibertz, F. et al. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. Cardiovasc. Res. 119, 2623–2637 (2023).
Seibertz, F. et al. Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes. Basic Res. Cardiol. 118, 14 (2023).
Paasche, A. et al. Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes. Basic Res. Cardiol. 119, 93–112 (2024).
Milligan, C. J. et al. Robotic multiwell planar patch-clamp for native and primary mammalian cells. Nat. Protoc. 4, 244–255 (2009).
Fakuade, F. E. et al. Impaired intracellular calcium buffering contributes to the arrhythmogenic substrate in atrial myocytes from patients with atrial fibrillation. Circulation 150 (2024).
Seibertz, F. & Voigt, N. High-throughput methods for cardiac cellular electrophysiology studies: the road to personalized medicine. Am. J. Physiol. 326, H938–H949 (2024).
McKeithan, W. L. et al. Reengineering an antiarrhythmic drug using patient hiPSC cardiomyocytes to improve therapeutic potential and reduce toxicity. Cell Stem Cell 27, 813–821 (2020).
Rapedius, M. et al. There is no F in APC: using physiological fluoride-free solutions for high throughput automated patch clamp experiments. Front. Mol. Neurosci. 15, 982316 (2022).
Obergrussberger, A. et al. The suitability of high throughput automated patch clamp for physiological applications. J. Physiol. 600, 277–297 (2021).
Stoelzle, S. et al. State-of-the-art automated patch clamp devices: heat activation, action potentials, and high throughput in ion channel screening. Front. Pharmacol. 2, 76 (2011).
Li, W. et al. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs. Stem Cell Res. 41, 101662 (2019).
Li, W. et al. Comprehensive promotion of iPSC-CM maturation by integrating metabolic medium with nanopatterning and electrostimulation. Nat. Commun. 16, 2785 (2025).
Brown, G. E. et al. Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation. Sci. Adv. 10, eadg1222 (2025).
Bloothooft, M. et al. Recording ten-fold larger IKr conductances with automated patch clamping using equimolar Cs+ solutions. Front. Physiol. 15, 1298340 (2024).
Li, W., Luo, X., Ulbricht, Y. & Guan, K. Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study. Stem Cell Res. 56, 102565 (2021).
Potet, F., Egecioglu, D. E., Burridge, P. W. & George, A. L. Jr. GS-967 and eleclazine block sodium channels in human induced pluripotent stem cell-derived cardiomyocytes. Mol. Pharmacol. 98, 540–547 (2020).
Geng, L. et al. Probing flecainide block of INa using human pluripotent stem cell-derived ventricular cardiomyocytes adapted to automated patch-clamping and 2D monolayers. Toxicol. Lett. 294, 61–72 (2018).
Becker, N. et al. Automated dynamic clamp for simulation of IK1 in human induced pluripotent stem cell–derived cardiomyocytes in real time using patchliner dynamite. Curr. Protoc. Pharmacol. 88, e70 (2020).
Mann, S. A. et al. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp. J. Pharmacol. Toxicol. Methods 100, 106599 (2019).
Sobitov, I. et al. Blebbistatin reduces calcium buffering in cardiomyocytes: consequences for cellular electrophysiology. J. Physiol. https://doi.org/10.1113/JP287545 (2025).
Sala, L. et al. A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Mol. Med. 8, 1065–1081 (2016).
Doss, M. X. et al. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on IKr. PLoS ONE 7, e40288 (2012).
Zhang, S. Isolation and characterization of IKr in cardiac myocytes by Cs+ permeation. Am. J. Physiol. 290, H1038–H1049 (2006).
Voigt, N. et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+–Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125, 2059–2070 (2012).
Voigt, N. et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129, 145–156 (2014).
Gutiérrez, L. K., Moreno-Manuel, A. I. & Jalife, J. Kir2.1-Na(V)1.5 channelosome and its role in arrhythmias in inheritable cardiac diseases. Heart Rhythm 21, 630–646 (2024).
Sager, P. T., Gintant, G., Turner, J. R., Pettit, S. & Stockbridge, N. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. Am. Heart J. https://doi.org/10.1016/j.ahj.2013.11.004 (2014).
Perszyk, R. E. et al. Automated intracellular pharmacological electrophysiology for ligand-gated ionotropic receptor and pharmacology screening. Mol. Pharmacol. 100, 73–82 (2021).
Clark, A. P., Wei, S., Christini, D. J. & Krogh-Madsen, T. Single-cell ionic current phenotyping elucidates non-canonical features and predictive potential of cardiomyocytes during automated drug experiments. J. Physiol. https://doi.org/10.1113/JP285120 (2024).
Kleinsorge, M. & Cyganek, L. Subtype-directed differentiation of human iPSCs into atrial and ventricular cardiomyocytes. STAR Protoc. https://doi.org/10.1016/j.xpro.2020.100026 (2020).
Knollmann, B. C. Induced pluripotent stem cell–derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ. Res. 112, 969–976 (2013).
Jung, P. et al. Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy. Basic Res. Cardiol. 117, 5 (2022).
Acknowledgements
We thank S. Kestel for excellent technical help and M. Dilaj for excellent secretarial assistance. This project was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, VO 1568/3-1, VO1568/4-1, VO1568/3-2, VO1568/6-1, SFB1002 project A13, and from the German Center for Cardiovascular Research (DZHK, 81×4300102, ‘DNAfix’) to N.V. This project was further supported by a grant from the DFG under Germany’s Excellence Strategy (EXC 2067/1—390729940) to N.V. and T.M. Last, this project was supported by the Else Kröner Fresenius Foundation through the Else Kröner Fresenius Center for Optogenetic Therapies for T.M.
Author information
Authors and Affiliations
Contributions
F.S., I.S., A.A., T.M., F.F., C.S. and N.V. designed and planned experiments. F.S., I.S., M.G. and A.A. analyzed the data. F.S., I.S., M.G., A.L. and A.A. established the methods and performed the experiments. F.S. and N.V. wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
F.S. became employed by Nanion Technologies GmbH (Germany) near the conclusion of this project. The other authors declare no competing interests.
Peer review
Peer review information
Nature Protocols thanks Henry Colecraft, who co-reviewed with Sri Karthika Shangmugam; and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key references
Seibertz, F. et al. Commun. Biol. 5, 969 (2022): https://doi.org/10.1038/s42003-022-03871-2
Kyriakopoulou, E. et al. Nat. Cardiovasc. Res. 2, 1262–1276 (2023): https://doi.org/10.1038/s44161-023-00378-9
Seibertz, F. et al. Cardiovasc. Res. 119, 2623–2637 (2023): https://doi.org/10.1093/cvr/cvad143
Seibertz, F. et al. Basic Res. Cardiol. 118, 14 (2023): https://doi.org/10.1007/s00395-022-00973-0
Fakuade, F. E. et al. Circulation 150, 544–559 (2024): https://doi.org/10.1161/CIRCULATIONAHA.123.066577
Supplementary information
Supplementary Information (download PDF )
Supplementary Methods 1–5, Figs. 1 and 2 and Table 1.
Supplementary Software 1 (download XLSX )
Example organizational analysis file for INa data.
Supplementary Software 2
File containing code for automatic extraction of desired data from result tables.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Seibertz, F., Sobitov, I., Gerloff, M.L. et al. A modular method for high-throughput measurement of ion channel currents in cardiac myocytes. Nat Protoc (2026). https://doi.org/10.1038/s41596-026-01351-z
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41596-026-01351-z


